Synthesis of pheophorbide-a conjugates with anticancer drugs as potential cancer diagnostic and therapeutic agents

Add time:09/09/2019    Source:sciencedirect.com

Pheophorbide-a, a chlorine based photosensitizer known to be selectively accumulated in cancer cells, was conjugated with anticancer drugs, doxorubicin and paclitaxel in the purpose of selective cancer diagnosis and therapy. Pheophorbide-a was conjugated with anticancer drugs via directly and by the use of selective cleavage linkers in cancer cell. The fluorescence of pheophorbide-a and doxorubicin conjugate by excitation at 420 or 440 nm was greatly diminished possibly by the energy transfer mechanism between two fluorescent groups. However, upon treatment in cancer cells, the conjugate showed to be cleaved to restore each fluorescence of pheophorbide-a and doxorubicin after 48 h of incubation. Also, pheophorbide-a conjugates either with doxorubicin and paclitaxel inhibited the growth of various cancer cells more potently than pheophorbide-a, which displayed very weak inhibitory activity. The results indicated that the pheophorbide-a conjugates with anticancer drugs could be utilized for selective cancer therapy as well as for the fluorescence detection of cancer.

We also recommend Trading Suppliers and Manufacturers of Pheophorbide A (cas 15664-29-6). Pls Click Website Link as below: cas 15664-29-6 suppliers

Prev:Original researchInvolvement of a Putative Bipartite Transit Peptide in Targeting Rice Pheophorbide A (cas 15664-29-6) Oxygenase into Chloroplasts for Chlorophyll Degradation during Leaf Senescence
Next:Evaluation of 99mTc-Pheophorbide-a use in infection imaging: A rat model)